CAR T-Cell Therapy Is Effective but Not Long-Lasting in B-Cell Lymphoma of the Brain

Advanced central nervous system (CNS) lymphoma is an exclusion criterion for most chimeric antigen receptor (CAR) T-cell studies due to the associated levels of neurotoxicity. In this study, we described five patients with chemorefractory B-cell CNS lymphoma who received CAR19 and CAR22 T-cell “Cock...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tongjuan, Zhao, Lei, Zhang, Yuanyuan, Xiao, Yi, Wang, Di, Huang, Liang, Ma, Liya, Chen, Liting, Liu, Songya, Long, Xiaolu, Meng, Fankai, Zhu, Xiaojian, Wei, Jia, Xu, Bin, Zhou, Jianfeng, Zhou, Xiaoxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438944/
https://www.ncbi.nlm.nih.gov/pubmed/32903866
http://dx.doi.org/10.3389/fonc.2020.01306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438944/
https://www.ncbi.nlm.nih.gov/pubmed/32903866
http://dx.doi.org/10.3389/fonc.2020.01306

Ejemplares similares